These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1639748)

  • 1. Do monoamine oxidase inhibitors alter carbamazepine blood levels?
    Barklage NE; Jefferson JW; Margolis D
    J Clin Psychiatry; 1992 Jul; 53(7):258. PubMed ID: 1639748
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of various monoamine oxidase inhibitors on the structure of the sleep-wakefulness cycle of the cat].
    Oniani TN; Akhvlediani GR
    Fiziol Zh SSSR Im I M Sechenova; 1987 Mar; 73(3):332-7. PubMed ID: 3582693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition.
    Mann JJ
    J Clin Psychopharmacol; 1983 Dec; 3(6):363-6. PubMed ID: 6315778
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of five clinically used inhibitors of monoamine oxidase using the fluorescence microscopy method.
    Bartonícek V
    Med Pharmacol Exp Int J Exp Med; 1967; 16(2):142-6. PubMed ID: 5298397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of monoamine oxidase inhibitors on the tryptamine content of the rat brain and on "tryptamine convulsions"].
    Popov N; Lietz W; Matthies H
    Acta Biol Med Ger; 1967; 18(2):233-44. PubMed ID: 5586804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
    Stanton HC; Schwartz A
    Proc West Pharmacol Soc; 1966; 9():6-8. PubMed ID: 4381147
    [No Abstract]   [Full Text] [Related]  

  • 10. Reversibility of MAO inhibition.
    Baxter LR
    J Clin Psychiatry; 1984 May; 45(5):234. PubMed ID: 6725215
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of some monoamine oxidase inhibitors on the refractory period of isolated rabbit auricles.
    Bose D
    Indian J Physiol Pharmacol; 1968 Jan; 12(1):63-4. PubMed ID: 5673672
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of dopamine and MAO inhibitors on centrally stimulated vomiting].
    Förster W; Gräbner S
    Acta Biol Med Ger; 1966; 16(6):650-7. PubMed ID: 4383660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 14. Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
    Baker GB; Coutts RT; McKenna KF; Sherry-McKenna RL
    J Psychiatry Neurosci; 1992 Nov; 17(5):206-14. PubMed ID: 1362653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAOI-carbamazepine combination and statistical power.
    Blanco-Jerez C; Robles DE; Gilaberte-Asin I; Blanco C
    J Clin Psychiatry; 1996 Jul; 57(7):311-2. PubMed ID: 8666579
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of monoamine oxidase inhibitors and reserpine on the gamma-aminobutyric acid content of the rat brain].
    Popov N; Matthies HJ
    Acta Biol Med Ger; 1967; 18(1):91-8. PubMed ID: 5587220
    [No Abstract]   [Full Text] [Related]  

  • 18. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination monoamine oxidase inhibitor and beta-blocker treatment of migraine, with anxiety and depression.
    Merikangas KR; Merikangas JR
    Biol Psychiatry; 1995 Nov; 38(9):603-10. PubMed ID: 8573662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.